Technology | November 24, 2014

Imaging bulk pack minimizes risk, increases safety and efficiencies

Bracco Creates Multi-Dose Compliant Contrast Medium for Point-of-Care Use in the CT Suite

November 24, 2014 — Bracco Diagnostics Inc. announced the availability of its Isovue (iopamidol injection) Imaging Bulk Package (IBP), a specific combination multi-patient, multi-dose compliant contrast medium approved by the U.S. Food and Drug Administration (FDA) for point-of-care use in the computed tomography (CT) suite.

The Isovue IBP was designed to increase safety and improve workflow, while minimizing risk and maintaining compliance regarding the use of multi-dose contrast media for radiological procedures in the CT suite.

Pharmacy Bulk Packages (PBPs) for multi-dose contrast media were originally approved in the 1990s with prescribing information for use in a “suitable work area, such as laminar flow hood, using an aseptic (sterile) technique,” typically found in the hospital pharmacy setting. Over time, The Joint Commission, which accredits and certifies healthcare organizations nationwide, began issuing citations to medical centers for using PBPs to transfer contrast media outside of the pharmacy in conditions that were not fully compliant with prescribing information. In 2012, the Institute for Safe Medication Practices called for hospital pharmacy oversight on the purchase, distribution, storage and use of intravenous contrast media, the use of single dose vials or pre-filled syringes for radiological use, and the proper use of PBPs.

The Isovue IBP allows for easy and cost-effective intravenous contrast enhancement of CT imaging of the head and body in adult and pediatric patients. It provides 10-hour on-demand dosing from the same container without the risk of incurring multi-dosing citations associated with transferring contrast media outside the hospital pharmacy setting.

For more information: www.braccoimaging.com

Related Content

News | Computed Tomography (CT)

December 1, 2021 — Researchers in Germany identified bone disease in the fossilized jaw of a Tyrannosaurus rex using a ...

Time December 01, 2021
arrow
News | Computed Tomography (CT)

November 30, 2021 — A three-year study of more than 1,000 patients found that the risk of delayed intracranial ...

Time November 30, 2021
arrow
News | Coronavirus (COVID-19)

November 29, 2021 — The largest multi-institutional international study to date on brain complications of COVID-19 has ...

Time November 29, 2021
arrow
News | Artificial Intelligence

November 28, 2021 — Lunit, a medical AI provider, is returning to the 107th Radiological Society of North America (RSNA) ...

Time November 28, 2021
arrow
News | Computed Tomography (CT)

November 28, 2021 — Detection Technology, a leader in X-ray detector solutions, unveiled the industry’s first off-the ...

Time November 28, 2021
arrow
News | Computed Tomography (CT)

November 28, 2021 — Royal Philips, a leader in health technology, unveiled its vision for interventional medicine by ...

Time November 28, 2021
arrow
News | Coronavirus (COVID-19)

November 24, 2021 — Significant decreases in CT imaging for cancer persisted even after the peak of the COVID-19 ...

Time November 24, 2021
arrow
News | Lung Imaging

November 23, 2021 — Median Technologies announces new outstanding performance of its lung cancer screening (LCS) CADx1 ...

Time November 23, 2021
arrow
News | Lung Imaging

November 19, 2021 — Lung cancer screening is recommended only for those who are at high risk for the disease — adults ...

Time November 19, 2021
arrow
News | Artificial Intelligence

November 17, 2021 — Lunit, a leading medical artificial intelligence (AI) provider, announced it has received U.S. Food ...

Time November 17, 2021
arrow
Subscribe Now